Gene That Inhibits Pancreatic Cancer Spread Identified

A gene that inhibits the spread of pancreatic cancer tumours has been discovered by scientists. This key finding paves way for targeted treatment of one of the deadliest forms of the disease.

After discovering the gene dubbed USP9X at work in a study of pancreatic cancer in mice, the international research team found it also played a role in humans.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

"We looked in human tumour specimens and we found that it was missing in a fraction of patients -- the patients that did very poorly ... the people who died the fastest," researcher David Tuveson told AFP.

"Patients that had a low level of the gene expressed ... they died very quickly after their operation and the patients who at the end of their life had lots of metastasis (spreading of the cancer), they had also a very low level of this protein."

The existence of the gene, which is found in all of our cells but goes missing in some tumours, was known before but not its role as a cancer suppressor, said Tuveson.

Quiz on Pancreas
Pancreas is both an endocrine and an exocrine organ. It secretes insulin, which is required for sugar breakdown. To learn more about the unique functions of the pancreas, engage in the following quiz.

Three other pancreatic tumour suppressor genes are known to exist, but this is the one whose absence "probably causes metastasis -- that is what kills people with pancreas cancer," said the scientist.

The discovery means that "we can wake up the gene by using drugs" known as epigenetic modulators, he added.

Mice Study: Nutritional Supplement may Inhibit Growth of Pancreatic Cancer Cells
A Mayo Clinic study has found that gamma-linoleic acid can inhibit the growth of a subset of pancreatic cancer cells in mice

"Our observation allows us to potentially treat people that have lost this gene in the pancreas tumours. It allows us to offer a therapy for the patients that actually have the worst prognosis."

Tuveson said these kinds of drugs have already been developed, "but people haven't figured out where exactly they would be useful.

Vaccine Therapy Linked to Stable Disease In Pancreatic Cancer
Stable disease in patients who are not candidates for surgery suggests being linked to a series of vaccine injections administered directly into a pancreatic cancer tumor.

"We are proposing that these drugs would be useful in this subset of pancreas cancer patients."

Pancreatic cancer kills about 96 percent of its victims within five years of diagnosis, one of the lowest cancer survival rates.

Early diagnosis is difficult, so the disease is often discovered only after it has already spread.

Source-AFP